FDA Paper To Address Cross-Labeling For Combination Products
This article was originally published in The Gray Sheet
Executive Summary
FDA is developing a document to help clarify some thorny issues related to cross-labeling of combination products and plans to host a public meeting on the issue soon, industry sources say